These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8896785)

  • 21. Diagnosing and treating bipolar disorder.
    Clayton P
    Minn Med; 1999 Oct; 82(10):46-8. PubMed ID: 10544645
    [No Abstract]   [Full Text] [Related]  

  • 22. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The broad spectrum of bipolar disorder: implications for research and practice -- a commentary.
    Young AH
    J Psychopharmacol; 2008 Jun; 22(4):401; discussion 408. PubMed ID: 18635716
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and efficacy of carbamazepine extended-release capsules in patients with bipolar disorder: QD vs BID.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():27-30. PubMed ID: 16754410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
    Oostervink F; Nolen WA; Hoenderboom AC; Kupka RW
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):401-4. PubMed ID: 10719540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Let's talk facts about bipolar disorder (manic depression).
    American Psychiatric Association
    J Okla State Med Assoc; 2008 Dec; 101(12):343-5. PubMed ID: 19177996
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychosensory symptoms in bipolar disorder.
    Ali SO; Denicoff KD; Ketter TA; Smith-Jackson EE; Post RM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct; 10(4):223-31. PubMed ID: 9359118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical use of carbamazepine. Review of the literature and personal results].
    Botte L; Charles G
    Acta Psychiatr Belg; 1988; 88(3):181-94. PubMed ID: 3068954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Administration of high dose levothyroxine in treatment of rapid cycling bipolar disorders. Review of the literature and initial therapeutic application apropos of 6 cases].
    Afflelou S; Auriacombe M; Cazenave M; Chartres JP; Tignol J
    Encephale; 1997; 23(3):209-17. PubMed ID: 9333552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The broad clinical spectrum of bipolar disorder: implications for research and practice.
    Smith D; Ghaemi S; Craddock N
    J Psychopharmacol; 2008 Jun; 22(4):397-400. PubMed ID: 18635715
    [No Abstract]   [Full Text] [Related]  

  • 31. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant treatment practice in the face of STAR*D and STEP-BD.
    Cassidy F
    Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512
    [No Abstract]   [Full Text] [Related]  

  • 33. Overcoming the current approach in bipolar disorder research: towards DSM-V and beyond.
    Vieta E
    J Psychopharmacol; 2008 Jun; 22(4):406-7; discussion 408. PubMed ID: 18635719
    [No Abstract]   [Full Text] [Related]  

  • 34. Commentary on the paper of Smith, et al.
    Angst J
    J Psychopharmacol; 2008 Jun; 22(4):404-5; discussion 408. PubMed ID: 18635718
    [No Abstract]   [Full Text] [Related]  

  • 35. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for depression and bipolar disorder.
    Treat Guidel Med Lett; 2010 May; 8(93):35-42. PubMed ID: 20414177
    [No Abstract]   [Full Text] [Related]  

  • 37. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open-label trial of adjunctive oxcarbazepine for bipolar disorder.
    Conway CR; Chibnall JT; Nelson LA; McGuire JM; Abraham PF; Baram VY; Grossberg GT; Carroll BJ
    J Clin Psychopharmacol; 2006 Feb; 26(1):95-7. PubMed ID: 16415718
    [No Abstract]   [Full Text] [Related]  

  • 39. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.
    Zarate CA; Payne JL; Singh J; Quiroz JA; Luckenbaugh DA; Denicoff KD; Charney DS; Manji HK
    Biol Psychiatry; 2004 Jul; 56(1):54-60. PubMed ID: 15219473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bipolar disorder.
    Gross R; Das AK; Weissman MM
    N Engl J Med; 2004 Dec; 351(23):2454-5. PubMed ID: 15575069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.